These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8149134)

  • 21. Down's syndrome and Alzheimer's disease: towards secondary prevention.
    Ness S; Rafii M; Aisen P; Krams M; Silverman W; Manji H
    Nat Rev Drug Discov; 2012 Sep; 11(9):655-6. PubMed ID: 22935789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of apolipoprotein E isotypes on Alzheimer's disease pathology in 40 cases of Down's syndrome.
    Wisniewski T; Morelli L; Wegiel J; Levy E; Wisniewski HM; Frangione B
    Ann Neurol; 1995 Jan; 37(1):136-8. PubMed ID: 7818249
    [No Abstract]   [Full Text] [Related]  

  • 23. Alzheimer's dementia and Down's syndrome: genetic evidence suggesting an association.
    Heston LL
    Ann N Y Acad Sci; 1982; 396():29-37. PubMed ID: 6217774
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cytogenetic study and chromosome abnormalities of Alzheimer's disease and Down's syndrome].
    Asaka A
    Nihon Rinsho; 1988 Jul; 46(7):1502-7. PubMed ID: 2975715
    [No Abstract]   [Full Text] [Related]  

  • 25. [New physiopathological mechanisms in Alzheimer's disease and Down's syndrome].
    Salamanca-Gómez F
    Gac Med Mex; 1998; 134(2):251-2. PubMed ID: 9619004
    [No Abstract]   [Full Text] [Related]  

  • 26. Molecular mapping of Alzheimer-type dementia in Down's syndrome.
    Prasher VP; Farrer MJ; Kessling AM; Fisher EM; West RJ; Barber PC; Butler AC
    Ann Neurol; 1998 Mar; 43(3):380-3. PubMed ID: 9506555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Down's syndrome and dementia].
    Parajuá-Pozo JL; Casis-Arguea S
    Rev Neurol; 2000 Jul 16-31; 31(2):126-8. PubMed ID: 10951667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Normal inhibition of DNA synthesis following gamma-irradiation of radiosensitive cell lines from patients with Down's syndrome and Alzheimer's disease.
    Lavin MF; Bates P; Le Poidevin P; Chen PC
    Mutat Res; 1989 Jul; 218(1):41-7. PubMed ID: 2526297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. microRNA 155 up regulation in the CNS is strongly correlated to Down's syndrome dementia.
    Tili E; Mezache L; Michaille JJ; Amann V; Williams J; Vandiver P; Quinonez M; Fadda P; Mikhail A; Nuovo G
    Ann Diagn Pathol; 2018 Jun; 34():103-109. PubMed ID: 29661714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alzheimer's disease and senile dementia: genetic relationships to Down's syndrome and hematologic cancer.
    Heston LL
    Res Publ Assoc Res Nerv Ment Dis; 1979; 57():167-76. PubMed ID: 154163
    [No Abstract]   [Full Text] [Related]  

  • 31. A quartet of Down's syndrome, Alzheimer's disease, cerebral amyloid angiopathy, and cerebral haemorrhage: interacting genetic risk factors.
    McCarron MO; Nicoll JA; Graham DI
    J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):405-6. PubMed ID: 9728967
    [No Abstract]   [Full Text] [Related]  

  • 32. Alzheimer's disease and maternal age.
    Cohen D; Eisdorfer C; Leverenz J
    J Am Geriatr Soc; 1982 Oct; 30(10):656-9. PubMed ID: 6214576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cytogenetical study of patients with Down's syndrome (author's transl)].
    Tomasić VK
    Lijec Vjesn; 1976 Mar; 98(2):139-42. PubMed ID: 133278
    [No Abstract]   [Full Text] [Related]  

  • 34. Small cerebral hemispheres in adults with Down's syndrome: contributions of developmental arrest and lesions of Alzheimer's disease.
    de la Monte SM; Hedley-Whyte ET
    J Neuropathol Exp Neurol; 1990 Sep; 49(5):509-20. PubMed ID: 2148772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Down's syndrome. I. Cytogenetics.
    Maximilian C; Duca D; Pop T; Toncescu N; Ioan D
    Endocrinologie; 1980; 18(4):273-5. PubMed ID: 6451918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
    Rumble B; Retallack R; Hilbich C; Simms G; Multhaup G; Martins R; Hockey A; Montgomery P; Beyreuther K; Masters CL
    N Engl J Med; 1989 Jun; 320(22):1446-52. PubMed ID: 2566117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study.
    Huang W; Alexander GE; Daly EM; Shetty HU; Krasuski JS; Rapoport SI; Schapiro MB
    Am J Psychiatry; 1999 Dec; 156(12):1879-86. PubMed ID: 10588400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levels of phospholipid catabolic intermediates, glycerophosphocholine and glycerophosphoethanolamine, are elevated in brains of Alzheimer's disease but not of Down's syndrome patients.
    Blusztajn JK; Lopez Gonzalez-Coviella I; Logue M; Growdon JH; Wurtman RJ
    Brain Res; 1990 Dec; 536(1-2):240-4. PubMed ID: 2150771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuronal RNA oxidation in Alzheimer's disease and Down's syndrome.
    Nunomura A; Perry G; Hirai K; Aliev G; Takeda A; Chiba S; Smith MA
    Ann N Y Acad Sci; 1999; 893():362-4. PubMed ID: 10672267
    [No Abstract]   [Full Text] [Related]  

  • 40. A case-control study of apolipoprotein E genotypes in Alzheimer's disease associated with Down's syndrome. Dutch Study Group on Down's Syndrome and Ageing.
    van Gool WA; Evenhuis HM; van Duijn CM
    Ann Neurol; 1995 Aug; 38(2):225-30. PubMed ID: 7654070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.